(Q37767426)

22 August 2017

1 reference

title

Methylene blue for the treatment of septic shock (English)

1 reference

22 August 2017

0 references

1 reference

Christopher A Paciullo

1

1 reference

22 August 2017

Deanna McMahon Horner

2

1 reference

22 August 2017

Kevin W Hatton

3

1 reference

22 August 2017

Jeremy D Flynn

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

30

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

702-715

1 reference

Current epidemiology of septic shock: the CUB-Réa Network.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

The pathophysiology and treatment of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Nitric oxide synthases: Roles, tolls, and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Administration of methylene blue in human septic shock: renaissance of an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Methemoglobinemia: etiology, pharmacology, and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Methylene blue for management of Ifosfamide-induced encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Methylene blue for ifosfamide-associated encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Inhibition of nitric oxide synthesis by methylene blue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Pharmacokinetics of Highly Ionized Drugs II: Methylene Blue—Absorption, Metabolism, and Excretion in Man and Dog after Oral Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Pharmacokinetics and organ distribution of intravenous and oral methylene blue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Continuous infusion of methylene blue for septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Effect of methylene blue on middle cerebral artery flow velocity in a patient with severe sepsis following clipping of a cerebral aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Methylene blue increases myocardial function in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Methylene blue administration in septic shock: a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Short-term beneficial effects of methylene blue on kidney damage in septic shock patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Effect of methylene blue on refractory neonatal hypotension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

An expanded definition of the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Acute renal failure and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Methemoglobinemia induced by methylene blue pertubation during laparoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Rediscovery of the susceptibility of G6PD deficient persons to methemoglobinemia from oxidant drugs, and to hemolysis from methylene blue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, p

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

Association between mitochondrial dysfunction and severity and outcome of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.7.702

21 January 2018

Identifiers

DOI

10.1592/PHCO.30.7.702

1 reference

22 August 2017

1 reference